The UK Drug Regulatory Agency has reported 242 rare blood clots and 49 deaths
The scientific committee responsible for overseeing the vaccination campaign Coronavirus disease inside United Kingdom Suggest Friday AstraZeneca Only 242 cases and 49 cases were recorded, which is only applicable to people over 40 years old A rare thrombotic death.
The Joint Committee on Vaccination and Immunization has recommended in April that AstraZeneca/Oxford serum should only be used for Over 30 years old The farther the better.
The British drug regulatory agency MHRA announced at a press conference that among the population who had received 28 million doses of Oxford/AstraZeneca vaccination, 242 rare blood clot cases had been recorded, of which 49 had died.
However, according to June Raine, the person in charge, for most people (especially the elderly), the benefits of vaccination still outweigh the risk of disease, because the elderly are more likely to develop severe forms of covid-19.
Due to these abnormal thrombosis, some European countries stopped using vaccines developed by scientists from the British-Swedish laboratory AstraZeneca and Oxford University at a certain age.
London has always defended and defended the “success of British science” proposed by British Prime Minister Boris Johnson.
He said that the British health authorities will follow the recommendations of the scientific committee “as a preventive measure” and, if possible, use alternative vaccines to “people under the age of 40 with no underlying health conditions”.
However, he emphasized that this should not delay the speed of vaccination, and the aim is to provide the first dose of vaccine to all adults in the country by the end of July.
Similarly, all have received the first dose AstraZeneca/Oxford They should receive a second dose of the same vaccine regardless of age, except for those with thrombosis.
In April, the European Medicines Agency (EMA) stated Blood clot They must list it as a “very rare” side effect of the AstraZeneca vaccine, taking into account that the benefit/risk balance is still “positive”.
In addition to AstraZeneca, Pfizer/BioNTech and Moderna vaccines are currently licensed in the UK, one of which is Vaccination campaign The most advanced in the world.
Of the total population of 66.5 million, nearly 35 million received the first dose of treatment, while in the countries most affected by Covid-19 in Europe, more than 16 million received two necessary doses of treatment, with more than 127,000 deaths.